Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: A systematic review

Journal of Wound Care

Volumn 23, Issue 10, 2014, Pages 510-516

  Moran, M E ^a  

^a KEAN UNIVERSITY   (United States)

Author keywords

Chronic digital ulcers; Scleroderma; Systematic sclerosis; Therapeutic modalities; Wound healing

Indexed keywords

COMPLICATION; COMPRESSION BANDAGE; EVIDENCE BASED MEDICINE; FINGER INJURIES; HUMAN; HYPERBARIC OXYGEN; SCLERODERMA, SYSTEMIC; ULCER; VACUUM ASSISTED CLOSURE; WOUND HEALING;

COMPRESSION BANDAGES; EVIDENCE-BASED MEDICINE; FINGER INJURIES; HUMANS; HYPERBARIC OXYGENATION; NEGATIVE-PRESSURE WOUND THERAPY; SCLERODERMA, SYSTEMIC; ULCER; WOUND HEALING;

EID: 84907887950     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2014.23.10.510     Document Type: Review

References (33)

1. Hinchcliff, M., Varga, J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician 2008; 78: 8, 961-968.
2. Poole, J.L., Watzlaf, V.J., D'Amico, F. A five-year follow-up of hand function and activities of daily living in systemic sclerosis (scleroderma). J Hand Ther 2004; 17: 4, 407-411.
3. Guiducci, S., Giacomelli, R., Cerinic, M.M. Vascular complications of scleroderma. Autoimmun Rev 2007; 6: 8, 520-523.
4. Schiopu, E., Impens, A., Phillips, K. Digital Ischemia in Scleroderma Spectrum of Diseases, Int J Rheumatol 2010; 2010, 1-8. Available from: URL: http://dx.doi.org/10.1155/2010/923743
5. Denton, C.P., Krieg, T., Guillevin, L. et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Ann Rheum Dis 2012; 71: 5, 718-721.
6. Matucci-Cerinic, M., Seibold, J.R. Digital ulcers and outcomes assessment in scleroderma. Rheumatology 2008; 47 (Suppl 5): v46-v47.
7. Patel, R.M., Nagle, D.J. Nonoperative management of scleroderma of the hand with tadalafil and subatmospheric pressure wound therapy: case report. J Hand Surg Am 2012; 37: 4, 803-806.
8. Steen, V., Denton, C.P., Pope, J.E., Matucci-Cerinic, M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology 2009; 48:(Suppl. 3): 19-24.
9. Brown, S. Management of digital ulcers related to systemic sclerosis. Nurs Stand 2010; 24: 32, 53-54.
10. Khimdas, S., Harding, S., Bonner, A. et al. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Arthritis Care Res 2011; 63: 1, 142-149.
11. Krishnan, E., Sokka, T., Häkkinen, A. et al. Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum 2004; 50: 3, 953-960.
12. Khanna, D., Furst, D.E., Clements, P.J. et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol. 2005; 32: 5, 832-840.
13. Bérezné, A., Seror, R., Morell-Dubois, S., et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res 2011; 63: 2, 277-285.
14. Chung, L., Fiorentino, D. A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis. J Am Acad Dermatol 2006; 54: 5, 880-882.
15. Amanzi, L., Braschi, F., Fiori, G. et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology 2010; 49: 7, 1374-1382.
16. Herrick, A.L. Contemporary management of Raynaud's phenomenon and digital ischaemic complications. Curr Opin Rheumatol 2011; 23: 6, 555-561.
17. Moore, S.C., DeSantis, E.R. Treatment of complications associated with systemic sclerosis. Am J Health Syst Pharm 2008; 65: 4, 315-321.
18. Matucci-Cerinic, M., Denton, C.P., Furst, D.E. et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 2011; 70: 1, 32-38.
19. Wasserman, A., Brahn, E. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy. Semin Arthritis Rheum 2010; 40: 2, 137-146.
20. Sherber, N.S., Wigley, F.M., Scher, R.K. Autoimmune disorders: nail signs and therapeutic approaches. Dermatol Ther 2007; 20: 1, 17-30.
21. Werdin, F., Tennenhaus, M., Schaller, H.E., Rennekampff, H.O. Evidence-based management strategies for treatment of chronic wounds. Eplasty 2009; 9: e9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691645/ (accessed 30 September 2014).
22. Hopf, H.W., Ueno, C., Aslam, R. et al. Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen 2006; 14: 6, 693-710.
23. Pfizenmaier, D.H., Kavros, S.J., Liedl, D.A., Cooper, L.T. Use of intermittent pneumatic compression for treatment of upper extremity vascular ulcers. Angiology 2005; 56: 4, 417-422.
24. Fiori, G., Galluccio, F., Braschi, F. et al. Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis. Clin Exp Rheumatol 2009; 27(Suppl. 54): 51-54.
25. Markus, Y.M., Bell, M.J., Evans, A.W. Ischemic scleroderma wounds successfully reated with hyperbaric oxygen therapy. J Rheumatol 2006; 33: 8,1694-1696.
26. Fleming, C.P. Acoustic pressure wound therapy in the treatment of a vasculopathyassociated digital ulcer: a case study. Ostomy Wound Manage 2008; 54: 4, 62-65.
27. Pinto, A.L., Oliveira, N.C., Gualano, B. et al.Efficacy and safety of concurrent training in systemic sclerosis. J Strength Cond Res 2011; 25: 5, 1423-1428.
28. Murray, A.K., Herrick, A.L., Gorodkin, R.E., et al. Possible therapeutic use of vasodilator iontophoresis. Microvasc Res 2005; 69: 89-94.
29. Murray, A.K., Moore, T.L., King, T.A., Herrick, A.L. Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis? Rheumatology 2008; 47: 1, 76-79.
30. Roustit, M., Blaise, S., Cracowski, J.L. Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis. Microvasc Res 2009; 77: 3, 260-264.
31. Roustit, M., Blaise, S., Arnaud, C. et al. Iontophoresis of endothelin receptor antagonists in rats and men. PLoS One 2012; 7: e40792. Available from: URL: http://www.plosone.org/article
32. Blaise, S., Roustit, M., Hellmann, M., et al. Cathodal Iontophoresis of Treprostinil Induces a Sustained Increase in Cutaneous Blood Flux in Healthy Volunteers. J Clin Pharmacol 2013; 53: 1, 58-66.
33. Sackett, D.L., Straus, S.E., Richardson, W.S. et al. Evidence-Based Medicine. How To Practice and Teach EBM. (2nd edn). Churchill Livingstone 2000.